HVHA

Name

HVHA

Legal name

苏州汇涵医用科技发展有限公司

Website

https://hvha.cn

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Wound Care Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Soap and Cleaning Compound Manufacturing (32561)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

akta.pro secondary industries

Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Wound care dressings
• Medical device manufacturing
• Bacterial cellulose technology
• Surgical instruments
• Biomedical materials

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Sales: Revenue from selling medical devices including wound dressings, surgical instruments, biomedical materials. Products include Class III medical devices like bacterial cellulose dressings and alginate silver dressings.
2. Medical Consumables: Daily medical and consumer products including disinfectants, protective equipment, and personal care products under brands like布林熊 (Disney licensing) for home care.
3. Biomedical Materials: Research and development sales of biomedical materials including recombinant proteins, enzymes, pharmaceutical intermediates.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

HVHA is a biological surgical technology company that manufactures and sells wound care medical devices (bacterial cellulose dressings, alginate silver dressings, hydrogels, silver-ion antimicrobial products), surgical instruments (electrocoagulation electrodes, thoracoscopy/laparoscopy instruments), biomedical materials (recombinant proteins, enzymes, pharmaceutical intermediates), and consumer health products including pet care items, family care disinfectants, and fermented fiber beverages. The company operates across five proprietary technology platforms—colloidal silver, hydrogel, bacterial cellulose, biological 3D, and metallothionein (MT)—and holds 50+ medical device registrations including 2-3 Class III certifications.

Product overview

苏州汇涵医用科技发展有限公司是一家融合科技、医疗与大健康消费的创新型企业，专注于生物医用材料的研发与产业化。公司依托络合银技术、水凝胶技术、细菌纤维素技术、生物3D技术及金属硫蛋白(MT)五大核心技术平台，形成了覆盖创面修复、手术器械、医学消费品、生物医药材料的四大业务板块。核心产品包括：汇涵皮纤生™细菌纤维素敷料和汇涵优贴®海藻酸钠银敷料两款III类高端医疗器械；汇涵术泰银离子抑菌剂、液体敷料、弹力绷带等创面修复系列产品；安能一次性使用电凝切割电极、胸腹腔镜等手术器械；布林熊、涵泰、汇雅佩特等家庭护理和宠物护理消费品牌；以及重组人源金属硫蛋白、酶制剂、医药中间体等生物医药材料。公司产品涵盖止血类、手术密封类、防黏连类、软组织管理类等全系列产品，已取得含3个三类医疗器械在内的50多张医疗器械注册证，拥有近100项核心专利技术，服务于国内外1500余家医院。

Differentiator

Problem solved

Functional benefit

Products and services

• Huihan Pixiansheng (汇涵皮纤生™) Bacterial Cellulose Dressing Class III medical device dressing for wound exudate absorption in deep II-degree burns, shallow wounds, postoperative suture sites, and chronic wounds; described as 'breathing artificial skin'; for hospital burn and wound departments.
• Huihan Youtie (汇涵优贴®) Alginate Silver Dressing Domestic high-end Class III medical device dressing meeting external-use antibiotic dressing gold standard, with proprietary patented technology for high-efficiency exudate absorption and physical antimicrobial/anti-infection; used for pressure ulcers, diabetic foot ulcers, and II-degree burns.
• Huihan Shutai Silver Ion Antibacterial Solution (汇涵术泰银离子抑菌剂) Silver ion antibacterial solution (240-280mg/L) effective against Staphylococcus aureus, Escherichia coli, and Candida albicans within 2 minutes; for daily skin cleaning and antibacterial use.
• Huihan Shutai Silver Ion Antibacterial Gel (汇涵术泰银离子抗菌凝胶) Silver ion gel (200-240ppm) with bactericidal action against E. coli, S. aureus, and Candida albicans within 2 minutes; for skin surface antibacterial cleansing.
• Huihan Liquid Dressing (汇涵术泰液体敷料) Hydrogel-based liquid wound-irrigation product designed for wound cleaning and promoting moist wound healing.
• ANONG Thoracoscopic and Gynecological Laparoscopic Surgical Instruments (安能胸腹腔镜手术器械) High-tech surgical instruments including thoracoscopes and gynecological laparoscopes, with complete equipment range and mature technology, produced by ANONG Medical Devices subsidiary.
• ANONG Disposable Electrocoagulation Cutting Electrode (安能一次性使用电凝切割电极) Class III medical device featuring lightweight ergonomic design with multiple blade options for different surgical needs, single-use to prevent cross-contamination.
• Sisi Buckle-in Self-adhesive Elastic Bandage (斯斯入扣自粘型弹力绷带) Self-adhesive elastic bandage using Japanese patented micro-cluster optical fiber as main component; skin-friendly, breathable, and tearable by hand; for clinical wound bandaging and sports protection.
• Recombinant Human Metallothionein Series (重组人源金属硫蛋白系列) Including Recombinant Human Metallothionein III, III α fragments, and II; used as free radical scavenger and antioxidant/anti-aging raw materials for pharmaceutical R&D, medical device development, cosmetics, and health food R&D.
• Enzyme Preparation Series (酶制剂系列) Including lysostaphin which has strong bactericidal action against drug-resistant S. aureus (MRSA); used for biological antibacterial agents, disinfectants, and medical device product development.
• Pharmaceutical Intermediates Series (医药中间体系列) Including 2'-deoxyadenosine (dA), 2'-deoxyinosine (dI), 2'-deoxythymidine (dT), and adenosine phosphate (AMP) among more than ten products; for antiviral, anti-AIDS, cardiovascular, and anticancer drug applications.
• Huiya Peite (汇雅佩特) Pet Antibacterial Gel Pet care antibacterial gel with bactericidal action against S. aureus, Pseudomonas aeruginosa, E. coli, and Candida albicans within 2 minutes; for pet skin antibacterial cleansing and small wound infection treatment.
• Huihan Fermented Fiber Beverage (汇涵一口轻纤维发酵饮品) Fermented fiber beverage made with 100% high-purity fermented fiber as core ingredient; 0 sugar, 0 fat, 0 protein, 0 trans-fatty acid, 0 sodium formulation; positioned for intestinal health.
• Bulinxiong Rinse-free Hand Disinfection Gel (布林熊免洗手消毒凝胶) Ethanol 70%-80% rinse-free hand disinfection gel for daily hygiene and surgical department rapid hand disinfection, marketed under Disney-licensed Bulinxiong brand.
• Sealed Negative Pressure Drainage Kit (封闭式负压引流套装) Negative pressure wound therapy kit for promoting wound healing, part of the company's full-series wound repair product line.
• Transparent Waterproof Dressing (透明防水敷料) Waterproof barrier dressing for wound coverage with waterproof isolation function, part of the wound repair full-series product line.
• Bacterial Cellulose Biological Dressing (细菌纤维素生物敷料) Bacterial cellulose dressing using patented bacterial cellulose technology, effectively preventing microbial invasion, alleviating wound infection and exudate problems, and promoting wound healing.
• Huihai Functional Proteins and Peptide Raw Materials (汇海功能性蛋白及多肽原料) Functional proteins, peptide raw materials, industrial enzyme preparations, green biosynthesis pharmaceutical intermediates, nucleic acid raw materials, and small nucleic acid-related upstream raw material products developed by Huihai (Suzhou) Biotechnology subsidiary via synthetic biology engineering platform.

Quantifiable outcome

• Products serve over 1500 hospitals across China
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• 北京科技大学, 北京工业大学, 海南大学, 北京科技职业大学, 上海中侨职业技术大学, 莆田学院coreStrategic or Co-development Partner · 8 June 2026Jointly developed the《细菌纤维素产品质量追溯规范》group standard. Multi-university collaboration for bacterial cellulose industry standardization.
• 西安交通大学 (Xi'an Jiaotong University)coreStrategic or Co-development Partner · 25 April 2025Invited to participate in key 'bottleneck' technology exchange meeting. Focused on biomedical materials innovation and '产学研用' collaborative innovation.
• 304医院/中国人民解放军总医院第三医学中心 (304 Hospital / PLA General Hospital Third Medical Center)coreStrategic or Co-development Partner · 25 April 2025CRO clinical cooperation and multi-center clinical observation projects. Long-term collaborative relationship for clinical research.
• 苏州工学院 (Suzhou Institute of Technology)minorStrategic or Co-development Partner · 9 April 2025School-enterprise cooperation meeting. University disciplines in machinery, intelligent manufacturing, enzyme molecular biology, and microbial fermentation align with HVHA's business areas.
• 韩国童颜针团队 (Korean Dermal Filler Team)minorStrategic or Co-development Partner · 16 April 2024Project cooperation agreement signed for dermal filler (童颜针) products. Korean team provides mature technology support, HVHA provides R&D and production capabilities.
• 上海工程技术大学 (Shanghai University of Engineering Science)minorStrategic or Co-development Partner · 2 April 2024School-enterprise cooperation meeting held April 2, 2025. Discussed cooperation in talent cultivation, scientific research innovation, and achievement transformation.
• 青岛海氏海诺集团有限公司 (Qingdao Haishi Hainuo Group)coreStrategic or Co-development Partner · 4 December 2023Strategic cooperation agreement signed December 4, 2023. Both companies agreed to leverage their respective resource advantages, broaden sales channels, conduct product cooperation, and jointly promote market publicity and sales work for mutual high-quality development.
• 上海顺筑医疗器械有限公司 (Shanghai Shunzhu Medical Devices)coreChannel Partner/ Reseller/ Distributor · 20 November 2023Strategic cooperation agreement for negative pressure drainage products signed November 20, 2023. Focus on deep service to end customers, expanding market coverage, improving production efficiency and scale.
• 付小兵院士团队 (Academician Fu Xiaobing Team)coreStrategic or Co-development Partner · 1 February 2023Bio-3D printing and wound emergency treatment technology transferred to HVHA. Led by Academician Fu Xiaobing from Military Medical Research Key Laboratory.
• 中国药科大学 (China Pharmaceutical University)coreStrategic or Co-development Partner · 1 January 2019Joint laboratory established in 2019. Collaborative research in biomedical materials and pharmaceutical applications.
• 东南大学, 苏州大学, 苏州健雄职业技术学院 (Southeast University, Soochow University, Suzhou Jianxiong Vocational College)coreStrategic or Co-development Partner · 1 January 2019Graduate internship and employment bases. '双元' faculty training workstation with Suzhou Jianxiong.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Mölnlycke Health Care: Mölnlycke is a Swedish global leader in wound care and surgical solutions (Mepilex, Mepitel). Direct competitor to HVHA in advanced wound dressings, with comparable hospital-channel commercialization in Asia and a similar proprietary materials-based approach.
• ConvaTec: UK-listed medical products company specializing in advanced wound care (Aquacel hydrofiber), ostomy, and continence care. Directly comparable to HVHA's wound-dressing portfolio with overlapping silver and hydrogel dressing technologies.
• Coloplast: Danish specialist in wound & skin care, ostomy, and continence care. Direct competitor in advanced wound dressings with strong global brand and similar focus on hospital-channel chronic wound management that HVHA addresses.
• Hollister Incorporated: US-based privately-held specialist in ostomy, continence, and advanced wound care (Hollister Wound Care). Similar private-company structure to HVHA with comparable wound-care portfolio and hospital-channel go-to-market approach.
• Integra LifeSciences: US-listed medical technology company with tissue engineering, wound care (Integra dermal matrix), and surgical instruments businesses. Highly comparable to HVHA's tissue-engineering + wound-dressing + surgical-instruments portfolio mix.
• Acelity (KCI/3M): Acelity (now part of 3M Solventum) is a wound-care specialist in negative pressure wound therapy (V.A.C.) and advanced dressings. Directly comparable to HVHA's negative-pressure drainage partnership with Shanghai Shunzhu and broader wound-care adjacency.

Broad incumbents

• Smith+Nephew: Smith+Nephew's Advanced Wound Management division is a global incumbent in wound care dressings (Allevyn, Acticoat silver). Competes with HVHA in hospital-grade dressings and is accelerating Asia expansion that directly pressures HVHA's domestic share.
• 3M Health Care (Solventum): 3M's Health Care business (now Solventum) includes a large wound care portfolio (Tegaderm) and surgical instruments. Broader incumbent with significant resource advantages and global scale in markets where HVHA is beginning to export.
• B. Braun: German medical technology company with a wound care division and surgical instruments that directly compete with HVHA's silver dressings and thoracoscopic/laparoscopic surgical instruments. Broader European incumbent with strong hospital relationships globally.

Emerging players

• Bloomage Biotech (华熙生物): Leading Chinese biotech built on hyaluronic acid fermentation technology. Closest domestic parallel to HVHA's bacterial cellulose platform approach: proprietary bio-fermentation IP repurposed across medical, consumer (functional foods), and pet segments - directly mirrors HVHA's medical-to-consumer extension playbook.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HVHA